Genetic element that enhances protein translation

US9234197B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9234197-B2
Application numberUS-201214349835-A
CountryUS
Kind codeB2
Filing dateOct 26, 2012
Priority dateOct 28, 2011
Publication dateJan 12, 2016
Grant dateJan 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides isolated polynucleotides that can serve as translation enhancing elements and their use in protein expression reagents and methods.

First claim

Opening claim text (preview).

We claim: 1. A recombinant viral or plasmid expression vector comprising (a) a translation enhancement element (TEE) of between 37 and 42 nucleotides in length, comprising the nucleic acid sequence of 5′-CATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO: 1); and (b) a cloning site located downstream of the TEE. 2. The expression vector of claim 1 , further comprising a promoter located upstream of the TEE. 3. The expression vector of claim 1 , further comprising a protein encoding nucleic acid cloned into the cloning site. 4. An isolated recombinant host cell comprising the expression vector of claim 1 . 5. A method for protein expression, comprising contacting the expression vector of claim 3 with reagents and under conditions for promoting expression of the protein encoded by the protein-encoding nucleic acid, and expressing the protein. 6. The method of claim 5 , wherein the protein is expressed in a cell-free translation system. 7. The method of claim 5 , wherein the protein is expressed by a recombinant host cell. 8. The method of claim 5 , wherein the expression vector is a recombinant vaccinia virus. 9. The method of claim 7 , wherein the recombinant host cell expresses the protein using non-viral-mediated translation. 10. An isolated recombinant virus, comprising the expression vector of claim 1 , wherein the expression vector is comprises a viral expression vector. 11. The recombinant virus of claim 10 , wherein the recombinant virus is a vaccinia virus, and the viral expression vector is a vaccinia virus expression vector. 12. The expression vector of claim 1 , wherein the TEE consists of 5′-CATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO: 1). 13. The expression vector of claim 1 , wherein the TEE consists of 5′-AGAACCATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO:2).

Assignees

Inventors

Classifications

  • being an enhancer not forming part of the promoter region · CPC title

  • General methods for enhancing the expression · CPC title

  • C12N15/85Primary

    for animal cells · CPC title

  • enhancing translation · CPC title

  • mammalian · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9234197B2 cover?
The present invention provides isolated polynucleotides that can serve as translation enhancing elements and their use in protein expression reagents and methods.
Who is the assignee on this patent?
Univ Arizona, Univ Arizona
What technology area does this patent fall under?
Primary CPC classification C12N15/85. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).